Tag: SING

420 with CNW – Marijuana Linked to Higher Sperm Concentrations

New research has revealed that men who smoke or have ever smoked cannabis have a higher concentration of sperm when compared to those who have never smoked marijuana. This study was conducted at Massachusetts General Hospital.

The team of researchers, led by a group based at Harvard Chan School of Public Health, based their work on a hypothesis that smoking marijuana would have an adverse effect (poor quality sperm) on the reproductive health of men.

They selected that hypothesis because some previous research seemed to suggest that smoking marijuana was detrimental to male reproductive health. However, those previous studies may have been flawed because they focused on men with drug abuse problems or the research was conducted on mice.

Nevertheless, this research sought to dig deeper into the link between smoking cannabis and sperm health.

To this end, the researchers obtained semen samples from 662 men. These samples (totaling 1,143) were collected for nearly two decades from 2000 to 2017. The men were approximately 36 years old and they were largely white with college degrees.

317 men from that group of participants also provided blood samples to the researchers. These blood samples were analyzed to check for the presence of reproductive hormones.

Additionally, the study participants were asked to fill a questionnaire about their use of marijuana. The questions included whether those men had ever smoked a total of two or more marijuana joints in their lives, and whether they were current cannabis smokers.

55 percent (a total of 365 of that group) of the study subjects admitted that they had ever smoked cannabis. From this number, 11 percent said they still smoked cannabis while 44 percent said they no longer did.

The researchers discovered that the men who smoked or had ever smoked cannabis had approximately 62.7 million sperms in each milliliter of ejaculate. The average sperm concentration for those who said they had never smoked cannabis was 45.4 million in each milliliter of ejaculate.

The World Health Organization puts the threshold for normal sperm concentration at 15million/mL of ejaculate. Interestingly, only 5 percent of the men who smoked cannabis had concentrations lower than this threshold while those who had never smoked had 12 percent of their members registering sperm concentrations that were below this threshold.

Serum testosterone was also higher among men who smoked or had ever smoked cannabis when compared to those who had never done so.

Feiby Nassan, the lead author of this research, warned that their findings should be taken with some caution because the researchers were aware that there is so much that may be going in the bodies of the study participants to explain why the results came out the way they did.

For example, the compounds in cannabis may work with the endocannabinoid system, thereby boosting male fertility.

On the other hand, one can also claim that men who have higher testosterone may be more likely to smoke cannabis since this hormone makes them more likely to indulge in risky behavior.

All in all, the researchers appealed for more research to be conducted on how marijuana affects the reproductive system and the entire body. This is exactly why cannabis industry players like Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) and SinglePoint, Inc. (OTCQB: SING) have been hoping that the U.S. federal government eases its restrictions on cannabis so that American researchers can add onto what researchers elsewhere are doing to increase the available knowledge about cannabis.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Why Suppositories will be Big in the Medical Marijuana Industry

Many people may feel rather squeamish about sticking a cannabis suppository up their backside, but this method of administration is beginning to attract widespread attention as a way to administer medical cannabis. Several reasons can explain their growing popularity.

Better Absorption Rates

The most common ways to take medical cannabis are by eating or smoking the substance. However, these two methods of administration don’t allow enough of the cannabis consumed to be absorbed into the bloodstream.

For example, the acidic environment inside the stomach and the entire gastrointestinal tract destroys most of the therapeutic ingredients in cannabis before those compounds have a chance to enter the bloodstream and do their work.

Smoking also comes with its own risks of damage to the lining of the lungs, among other dangers. Furthermore, not enough cannabis can be absorbed through the lungs since some is exhaled along with the air one breathes.

However, the lining of the rectum provides an excellent medium through which cannabis can be absorbed into the bloodstream. Consequently, a patient will not need to use a large dose in order to get the desired effects.

It’s Ideal for Seriously Ill People

Some patients, such as cancer patients, are in such a bad state that it is nearly impossible for them to smoke or consume cannabis edibles. How can such people get medical cannabis into their bloodstream?

Cannabis suppositories are an excellent option in such situations. Remember, all lists of conditions for which one can access medical cannabis include chronic or debilitating illnesses. No wonder doctors are increasingly recommending that patients use marijuana suppositories.

They Have a Track Record

Suppositories aren’t a new invention. They have been used in conventional medicine for decades. These items are therefore getting a new lease of life by being used in the medical cannabis industry.

Additionally, it is possible to standardize the dosing of cannabis products if patients are going to use suppositories. This is much better than telling someone to smoke “a thick wad of cannabis when the tremors start.”

Such standardization can go a long way in removing the stigma that has sometimes been directed at cannabis as something for reckless people who have nothing to do except getting high.

Less THC Is Absorbed in This Way

Another key advantage of cannabis suppositories is that they are likely to silence the critics who say that patients are using medical cannabis in order to get high.

Research has it that THC (the psychoactive element in cannabis) isn’t as readily absorbed into the bloodstream through the rectum, unlike CBD that is readily absorbed. Thus, there is a lower risk that patients will get addicted to cannabis while taking it anally.

As you can see, cannabis suppositories seem poised to stake their claim in the medical cannabis sector. The cannabis industry, including SinglePoint Inc. (OTCQB: SING) and Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4), welcomes all avenues through which patients can get relief from their conditions.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – About 60 Closed Cannabis Dispensaries May Reopen in Michigan

The Michigan Medical Marijuana Licensing Board has voted to allow more than 60 medical cannabis dispensaries to reopen at least until March 31 as their license applications are processed.

The decision was announced after there was an outcry that patients would find it hard to get medical cannabis if that large number of dispensaries is closed pending the processing of their license applications.

The reprieve given to the closed businesses is subject to a number of conditions. First, the local government of the area should have granted the business approval to operate in their jurisdiction. The business should have also submitted its license application within a certain timeframe, in addition to meeting the other conditions before it reopens.

This decision was met with some reservations by a section of the members of the licensing board. These individuals felt that letting these closed businesses to reopen would be unfair to those dispensaries that had done everything possible to acquire a license.

By reopening unlicensed dispensaries, the board may be setting a precedent that it makes no difference whether you comply with regulatory requirements in time or not.

These concerned board members were of the view that the 50 licensed dispensaries should have been given a chance to see a boom in their sales as a reward for taking timely action to get licensed. The unlicensed dispensaries are 72.

In a related development, medical marijuana products that haven’t been tested and approved can still be sold at the different dispensaries within Michigan as long as the dispensary gives the patient an acknowledgment form to sign confirming that the patient is aware that the product hasn’t met all the testing requirements of the state.

The previous Governor of Michigan, Rick Synder, had tried to close all the medical cannabis dispensaries that were still using the emergency rules as the basis of their operation before they get licenses.

However, those attempts to close the dispensaries were thwarted by court rulings and the desire to protect patients’ interests regarding ease of access to medical marijuana. This recent reprieve by the licensing board is yet another speed bump on the journey to accept only licensed dispensaries to operate in the state.

All in all, it is good that the interests of the patients have been given precedence by the medical marijuana licensing board in Michigan. Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) and SinglePoint, Inc. (OTCQB: SING) urge the affected dispensaries to comply with all the regulatory requirements so that their operations aren’t disrupted once the deadline reaches.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

New Laws Set Up US Cannabis Industry for Explosive Growth

CannabisNewsWire Editorial Coverage: The 2018 U.S. Farm Bill changes the way that CBD-based products are legally classified. If the federal government permits the sale of cannabis-sourced products online, established companies in the space could reap huge rewards.

  • The legalization of cannabis in Canada and some U.S. States has demonstrated the latent demand for cannabis-based products.
  • CBD is used to make numerous products and its potential uses are growing.
  • Research suggests that the market for CBD products could grow to an estimated $22 billion over the next four years.

SinglePoint Inc. (OTCQB: SING) (SING Profile) is in a good position to take full advantage of the changes in how CBD products are regulated. Major producers such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), Aphria Inc. (NYSE: APHA) (TSX: APHA), Medical Marijuana Inc. (OTC: MJNA) and OrganiGram Holdings Inc. (OTCQX: OGRMF) (TSX.V: OGI) are also well-placed to expand into the CBD space, but they may have to compete with a new class of growers.

There are more than 80 kinds of psychoactive compounds found in the cannabis plant. While most people are familiar with THC, which is used recreationally, CBD has shown promise in treating everything from insomnia to serious neurological disorders. The 2018 Farm Bill leaves THC-based products under the jurisdiction of the Drug Enforcement Agency (DEA) but gives jurisdiction of CBD-based products to the individual states. Most industry experts predict that the popularity of these products will explode as they become easily available due to the new regulations.

To view an infographic of this editorial, click here.

A Waiting Market

Until now, CBD-based products were subject to federal regulations, which made them impossible to distribute nationally. They have been sold on a statewide basis in areas that allowed their use, but anyone who dealt with these products was shut out of the federal banking system because the crop — and its subsequent products — were categorized as illegal at a federal level.

With the signing of the new legislation, that appears likely to change. SinglePoint (OTCQB: SING) is an established distributor of CBD products and owns a decade-old web domain. Not only does the company have experience with marketing and distributing CBD-based products, it also has a background in payments processing.

CBD-based products are a new, largely unfamiliar area that may pose challenges for new companies entering the space. Universal standards for many CBD products have yet to be established or identified, so having a positive market image will likely be a significant benefit. Established companies with an existing client base and a positive reputation may be in a better position to leverage growth in the CBD sector. SinglePoint seems to fit this criteria well.

Wide-Open Potential

There is a big difference between cannabis grown for medicinal use and hemp that can now be used as a feedstock for CBD in the United States. Major cannabis producers have a much higher cost of production than hemp growers. With new changes that the 2018 Farm Bill creates for hemp farmers, the price of CBD may fall substantially.

Instead of being cultivated in near-laboratory conditions, industrial hemp is grown like any other commercial crop. Now that CBD can be refined out of commercially produced hemp, it will be difficult for anyone but U.S. hemp farmers to compete on price when it comes to CBD.

Additionally, the 2018 Farm Bill normalizes the CBD economy at a federal level. For the first time, hemp growers can use the banking system, insure their crops, and even sell their future hemp production via futures. Like any new market, it will take time for the infrastructure to be developed, but early movers in the space may have a significant advantage.

Big Changes for CBD

SinglePoint is in a unique position in the emerging CBD space. As both an online marketer and payments processor, the company looks to be in a strong position to help deliver CBD products to their target markets. The company has a strong strategy to grow its presence in the CBD space. Unlike many of the other publicly traded, cannabis-focused companies, SinglePoint has no connection with cannabis plants and cultivation, so the company should be able to take full advantage of the recently passed 2018 Farm Bill.

It appears that there is no shortage of potential CBD-based products. Currently, CBD is integrated into everything from lotions and edibles to beer and oil. With the legalization of CBD widely anticipated, research will almost certainly lead to additional discoveries into CBD properties and benefits, as well as the creation of new products targeting specific market segments.

The emerging CBD economy is also supported by the ability for hemp producers to raise funds publicly. Much like the Canadian cannabis producers that were able to expand quickly because of their publicly traded equities, U.S. hemp producers can now go public and leverage public interest in CBD to expand their operations.

Changing Production Profiles

The 2018 Farm Bill is a huge positive for U.S.-based hemp producers and CBD consumers.

One of the largest publicly traded cannabis producers available to U.S. investors, Cronos Group (NASDAQ: CRON) (TSX: CRON) owns two fully licensed cannabis producers in Canada and has other interests spread around the world. The company has maintained a multibillion-dollar valuation, despite some weakness in the publicly traded cannabis sector. In addition to producing cannabis in Canada, the company is involved in the distribution of cannabis products in many of the markets in which it operates. In the third quarter last year, the company reported increased revenues by 186 percent and sold 213 percent more kilos of cannabis than in the same time a year earlier.

Aphria (NYSE: APHA) (TSX: APHA) has grown its presence in the Canadian cannabis space via acquisitions and strategic investments and is one of the largest publicly traded cannabis producers. The company made two high-profile acquisitions last year, taking over Broken Coast Cannabis and buying Nuuvera, a Canadian cannabis company with already-existing strategic exposure to German and Italian markets. The vast majority of the company’s production capacity for cannabis is concentrated in a single facility, called Aphria One, which is located in Leamington, Ontario.

Medical Marijuana (OTC: MJNA) has been operating in the legal cannabis space for longer than most. The company owns numerous subsidiaries, including HempMeds, Kannalife and Kannaway. It also operates an international division, which has developed a substantial presence in Brazil, where it was the first company to introduce legal cannabis-based medicines to the Brazilian market. The company also has a direct marketing structure for cannabis products and appears to be well-placed to grow in the emerging CBD market.

OrganiGram Holdings (OTCQX: OGRMF) (TSX.V: OGI) is the parent company of Organigram Inc., one of the largest licensed producers of cannabis in Canada. The company delivers industry-leading yields from its growing facilities and is focused on expanding in the Canadian market for recreational and medicinal cannabis. Organigram developed a portfolio of brands for a variety of uses, including The Edison Cannabis Company, Ankr Organics, Trailer Blazer and Trailer Park Buds. In addition to growing cannabis, OrganiGram also distributes it.

With the passage of the 2018 Farm Bill changing the legal status of CBD, it is estimated that the CBD market will grow to be a $22 billion industry by 2022. SinglePoint has created a solid platform to be a part of that industry.

For more information on SinglePoint, visit SinglePoint Inc. (OTCQB: SING)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Cannabis Concentrates Could Be Bigger than Edibles in Canada

Canada is slated to legalize cannabis edibles sometime this year and the population is filled with excitement regarding these products. However, if the trend in the U.S. states where edibles are legal is anything to go by, then edibles will not be the biggest moneymaker. Something else, concentrates, will be king of the market.

For example, edibles fetched $685 million from the start of 2018 to October the same year in Oregon, Colorado, California and Arizona. However, the same period saw consumers spending approximately $1.4 billion on marijuana concentrates.

The bulk of that money spent on cannabis concentrates was for marijuana vape pens and cannabis oil cartridges. These items alone accounted for $972 million in the months referred to earlier as captured in the statistics collected by BDS Analytics.

In the cannabis industry, vape pens are the modern or better version of cannabis joints in the same way that electronic cigarettes provide a better way to get your nicotine hit when compared to smoking a combustible cigarette.

Cannabis vape pens are discreet, not smelly and they are user-friendly when compared to the hassles that one has to go through to roll and light a joint.

The other cannabis concentrates on which Americans in the states named earlier spent money were hash oil, wax and shatter. These particular kinds of concentrates are intended for “dabbing.”

Thus, the evidence from the U.S. shows that cannabis concentrates are likely to fetch more money than the edibles that everyone is excited about.

These findings are given further credence when one considers the responses of ordinary people to different cannabis products. Many people will be more willing to try a vape pen rather than taking a puff on a joint if those people haven’t consumed cannabis before.

Interestingly, data from Canada shows that people have been consuming marijuana concentrates for a while. For example, a 2018 survey of approximately 13,000 cannabis consumers revealed that 26 percent had ever used hashish while 19 percent admitted that they had ever used a solid form of marijuana concentrate.

People opposed to cannabis edibles claim that these products will dominate the market and open the gate to the misuse of cannabis. However, the data collected over time shows that even if edibles grow in popularity, they will always fall behind concentrates and the dried bud in terms of market share.

Industry watchers and participants like Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) and SinglePoint, Inc. (OTCQB: SING) are waiting to see how events play out once edibles become legal throughout Canada.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Oregon Eases Access to Medical Marijuana

The authority in charge of overseeing cannabis in Oregon (the Oregon Liquor Control Commission) has released new rules that will make it easier for patients to access medical marijuana.

The new rules that are set to take effect tomorrow (December 28) will allow marijuana to be delivered to those areas where the local authorities have passed ordinances banning any marijuana-related business activity within their jurisdictions.

The new provision of the rules is welcome news to patients and caregivers because they will no longer have to travel long distances in order to replenish their medical cannabis supplies.

Additionally, the new rules have also increased the limit on how much cannabis one can buy at a go. Previously, a patient holding a medical cannabis card was only allowed to buy an ounce (28.3 grams) of cannabis.

This limitation was particularly hard on patients or caregivers from the areas where medical cannabis was prohibited. This is because such people would be compelled to make frequent trips to distant medical cannabis dispensaries.

The new rules now allow a patient or caregiver carrying a valid medical cannabis card to purchase up to 8 ounces (226.4 grams) of cannabis. This higher cap means that patients will now reduce how frequently they go to purchase replenishments.

Why the change of heart on the quantities?

It was previously feared that allowing medical cannabis cardholders to buy larger amounts of cannabis would create opportunities for the medical cannabis program to be used as a supply source for the recreational use of marijuana. However, this may have proved to be an unfounded fear.

Secondly, the inconvenience of having to go to a dispensary so frequently was burdensome to many patients and caregivers, so a concession on how much could be purchased was an inevitable compassionate step to take.

It is estimated that Oregon has approximately 50,000 people registered to access medical marijuana. The state legalized medical marijuana in 1998, and it has been updating its regulatory framework periodically, based on the changing realities within the state, and borrowing from the experiences of other states where medical marijuana has since been legalized. It is in this same spirit that plans are underway to pass permanent rules regulating CBD products and hemp in the wake of the passing of the Farm Bill 2018.

SinglePoint, Inc. (OTCQB: SING) and other industry participants like Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: 03X4) welcome the changes Oregon has made in response to the persistent problems that patients and their caregivers were experiencing.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Study Finds Proximity to Cannabis Dispensaries Increases New Home Prices

A recent study whose findings were published in the Contemporary Policy journal shows that prices of new homes jump by up to 7.7 percent in case a cannabis dispensary opens close to those homes.

The researchers compared the data for new homes in Denver, Colorado that were within quarter a mile, half a mile and three-quarters of a mile from a newly opened dispensary. The researchers discovered that the biggest increase (7.7 percent) in price occurred in the price of homes that were within quarter a mile from the cannabis dispensary.

The homes that were within half a mile (but beyond the quarter mile mark) had modest price increases of about 4.7 percent. However, these price hikes fizzled out as the distance between a new home and the cannabis dispensary increased.

It is also interesting to observe that the effect of cannabis dispensaries on housing prices mirrored the effect of new groceries or shopping malls in neighborhoods. However, the researchers refrained from trying to explain why the opening of a cannabis dispensary had such an effect on the price at which homes were sold. They could only guess that it may be due to the convenience of accessing the marijuana dispensary, especially when the public is positive towards marijuana in general.

Another study conducted thousands of miles away in the Netherlands seems to confirm that the findings in Colorado are valid. Igor Goncalves Koehne de Castro, a doctoral student, wrote a master’s dissertation about what happens when a cannabis coffee shop closes in a neighborhood.

He discovered that the rents paid by Airbnb clients reduced by approximately 3 percent in case a cannabis coffee shop closed within a radius of 250 meters from a facility registered on Airbnb.

Locations that were further than 250 meters from the closed coffee shop didn’t register any change in rents.

De Castro had plenty of case studies to follow since lots of coffee shops had closed within the four-year window he examined (2014-2017). Various factors, such as the enactment of laws barring cannabis coffee shops from operating within a certain radius from a school, compelled different marijuana coffee shops to close.

The statistical models from which he gathered his findings reveal that the coffee shops may be an attraction since Amsterdam is a tourist destination and visitors want to be within walking distance from a cannabis coffee shop.

This pair of studies in different geographical locations proves that cannabis legalization has widespread benefits beyond the ones immediately noticeable (taxes and direct jobs in the industry, for example). This also gives further justification that the Colorado jury which dismissed a claim that a marijuana grow facility depressed the value of a nearby property made a correct decision to throw out that claim.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) and other industry participants like SinglePoint, Inc. (OTCQB: SING) welcome this piece of additional positive news about the effects that cannabis is having upon the lives of people.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Marijuana Could Improve the Memory of Older People, Study Finds

Researchers from the University of Bonn in Germany and Hebrew University in Jerusalem (Israel) have done a study to investigate whether cannabis can improve brain function once endocannabinoid system (ECS) activity is increased by administering cannabis.

Lead researcher Andreas Zimmer and his team got three categories of mice for this study. The first group of mice was two months old while the second group was 12 months old. The third group of mice was 18 months old. These three groups represented the young, mature and old age-groups respectively.

The mice in each age group either received a placebo or had an implant that released THC slowly into the bloodstream. This was done consistently for 28 days after which several days were allowed to elapse with no THC being administered. This abstinence period was referred to as the washout period.

Additionally, all the mice (whether they got THC or a placebo) took part in memory and behavioral tests. For example, one activity involved testing whether the mice recognized other mice to which they had been exposed prior to receiving the placebo or THC.

Another test required the mice to locate a safe platform in a pool of water. The time taken during this activity was recorded for all the mice in the study.

The results of the study were eye-opening. For example, the young mice (the group which was two months old) showed a deterioration in their memory function after receiving THC. In contrast, the mature (12 months old) mice showed an improvement in their memory function. How could this be?

The researchers studied the brain structures of these mature mice and discovered that the brains suddenly looked young (comparable to those of the two-month old mice). Specifically, the hippocampus acquired new synaptic spines, a sign that brain neurons could now communicate more effectively with each other, and thereby heighten brain activity.

In other words, the THC had rewritten the genetic programming of the brains of the mature mice. The researchers used the elimination method to discount any other factor which could be responsible for the improved brain function and the result was that the THC reversed the aging of the brain cells.

What do these results mean for humans? The work done by Zimmer and his team shows a high likelihood that older humans can see improvements in brain function if they consume cannabis. However, this isn’t a certainty until human trials are done and documented. The good news is that Zimmer has already secured funding to study how THC affects memory function in humans.

The study involving human subjects will paint a clearer picture of how cannabis can be used to combat mental decline with age, especially dementia. Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4), SinglePoint, Inc. (OTCQB: SING) and the entire cannabis industry wish Zimmer and his team of researchers all the best in their bid to broaden how much we know about cannabis and its medicinal value.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Political Change and E-commerce Drive Ongoing Growth for Cannabis Industry

CannabisNewsWire Editorial Coverage: Years of steady growth in the cannabis industry are expected to continue.

  • Cannabis industry forecasts anticipate revenues of $146 billion by 2025.
  • Individual U.S. states are already seeing cannabis sales exceed $1 billion in a year.
  • The departure of Jeff Sessions and expected passage of the Farm Bill will bolster these profits.
  • E-commerce is helping cannabidiol (CBD) products reach a growing market.

SinglePoint, Inc. (OTCQB: SING) (SING Profile) is showing how much technology can boost the industry, with support software and an online store. Terra Tech Corp. (OTCQX: TRTC) is also profiting from supporting producers, through the sale of hydroponic equipment. American Premium Water Corp. (OTC: HIPH) (HIPH Profile) is providing innovative cannabis-based products in the form of its CBD-infused water. The Alkaline Water Company Inc. (TSX.V: WTER) (OTCQB: WTER) has announced the formation of a beverage division that will offer a hemp-derived, CBD-infused product, while Level Brands, Inc. (NYSE American: LEVB) is partnering with a pharmaceutical and wellness company to provide CBD cream, spray, and edible products.

To view an infographic of this editorial, click here.

Keeping Up the Cannabis Momentum

Turbulent times in the United States are creating uncertainty for a number of industries. But for the cannabis industry, the past few years have been ones of constant growth. The spread of recreational and medical marijuana legalization across the United States and Canada has given the industry a huge boost, both financially and in its public profile, as has the increasing popularity of CBD products.

That growth is expected to continue, in large part thanks to the momentum from political change. The departure of U.S. Attorney General Jeff Sessions offers the possibility that the White House may finally commit to President Donald Trump’s electoral promise of cannabis policy reform at the federal level. Meanwhile, the Democratic majority in the House, together with the hemp clauses in this year’s Farm Bill renewal, set the stage to make life easier for those looking to support the American hemp industry.

The Growth of Cannabis

The past few years have been good for cannabis and technology holding company SinglePoint, Inc. (OTCQB: SING). Like so many other companies working with cannabis, SinglePoint has benefited from a huge growth in business as a once-obscure sector of the economy turns into a growing powerhouse and major employer.

There’s an irony to the fact that, for most of the companies working in the cannabis space, being based in North America is what makes their business possible. Thirty years ago, this was the headquarters of the war on drugs — the U.S. government’s attempt to wipe out the cannabis industry alongside those producing and distributing other drugs. Now the United States and Canada are the world’s biggest markets for legal cannabis as reformers work to take pot profits away from criminal gangs and to bolster public health through a legal, well-regulated industry.

As of this year, cannabis is legal for medical consumption in two-thirds of U.S. states and for recreational use in a fifth of them. Recreational use became legal in Canada a month ago — the first G8 country to make such a move. This step forward has created a huge market for companies such as SinglePoint to tap into, with Colorado alone expecting to see a billion dollars of cannabis sales by the end of 2018.

This growth isn’t limited to cultivators and retailers, the obvious face of the cannabis industry. Those businesses need support services and infrastructure to do their work. SinglePoint provides a wide range of tech solutions tailored to the sector, including software to measure cultivation, track deliveries and make payments. Other businesses provide nutrients, hydroponic equipment and advisory services to the burgeoning cannabis sector.

This also means a growing number of jobs. These are diverse opportunities as well, with many of them involving specialist skills and training from bud tending to compliance, not to mention the coders crafting SinglePoint’s software. During a reporting period between January 2017 and July 2018, the number of job listings in the industry rose by a staggering 690 percent. And the global market is expected to exceed $146 billion in revenues by the end of 2025, driven in large part by events in North America.

Maintaining Marijuana’s Momentum

One of the most significant events of the past few weeks for the cannabis industry’s prospects has been the resignation of U.S. Attorney General Jeff Sessions.

An outspoken opponent of cannabis reform, Sessions tried to roll back the President Barack Obama-era policy in which the federal government, though still treating cannabis as illegal, accepted the decisions of individual states to legalize it. The federal-level illegality of cannabis is an ongoing problem for the industry for several reasons, including that it makes banks and payment providers wary of providing services to cannabis businesses. Companies such as SinglePoint offer alternative payment solutions, but federal laws still limit the options. Sessions’ departure may create a real potential for change.

“This could present a major opportunity for SinglePoint to offer services we have been able to provide to other businesses for years,” said SinglePoint president Wil Ralston. “The biggest winner here could be the ancillary service provides and the potential access to banking.”

During his election campaign, President Trump promised reform on cannabis. But after two years of a Trump White House, there’s been nothing more substantial than vague rumors. With Sessions gone, now may be the time to act as more states move to legalize cannabis. And even without federal reform, changes on the state level are still positive for the industry. As SinglePoint CEO Greg Lambrecht said in an interview with MoneyTV, “as more states come on, it’s just better for us.”

CBD: A Cannabis Surprise Hit

The other big political reform about to hit the industry is the 2018 Farm Bill. Delayed by political conflict over food stamps and immigration, the bill’s passage is now expected to speed up as Republicans push through a version they can live with before losing control of the House. This bill is set to legalize the hemp industry in the United States, allowing the cultivation of a nonpsychoactive form of cannabis.

Hemp promises to be a big cash crop. CBD oil extracted from hemp is used in a wide range of health and wellness products, such as the CBD water and tinctures recently released through SinglePoint’s SingleSeed site. The CBD side of the industry reaches markets that raw cannabis can’t and, as a result, has seen huge growth, spreading into health stores and international markets.

But it’s through e-commerce that CBD has really taken off. More than $4 million of CBD products were sold through Amazon just in July this year. For companies, such as SinglePoint, that are using their own e-commerce stores, there’s even greater potential for profit than through Amazon. By providing both the product and the marketplace, they create a complete funnel to customers, benefitting from all the profits and building a loyal client base.

Beyond Weed

As SinglePoint’s software and the growth of the CBD market show, the cannabis industry is about far more than just selling weed.

For Terra Tech Corp. (OTCQX: TRTC), the focus is on supplying equipment. A producer of cultivation equipment such as hydroponics and moving tables, Terra Tech provides cannabis growers with the tools they need to grow rich, profitable crops. The growth of the industry has increased sales for hydroponics companies, a trend that’s expected to continue. Terra Tech is investing heavily in a hydroponics provider to reduce its costs and improve its ability to ensure supplies to growers.

The growing popularity of CBD has drawn in companies from outside the cannabis industry as well. American Premium Water Corp. (OTC: HIPH) is a diversified luxury consumer product company that uses biotech as the basis for health and beauty merchandise. It has produced a CBD-infused drink — Lalpina CBD water — that makes it one of the first to turn CBD into a widely available edible product.

Alkaline Water Company, Inc. (OTCQB: WTER) (TSX.V: WTER) announced the formation of its A88 Infused Beverage Division, Inc. The company currently offers products trademarked Alkaline88 that are available in more than 40,000 retail locations across the United States, including 39 of the top 50 grocers in the country. The new division — A88 — will focus on brand extension and product innovations in the healthful water category, with plans to offer a hemp-derived, CBD-infused Alkaline88 water product.

Level Brands, Inc. (NYSE American: LEVB) has launched a new line of CBD products developed jointly with Isodiol International, Inc. The products include CBD oral sprays marketed under kathy ireland® Health & Wellness; CBD edibles marketed under Chef Andre Carthen Edibles; and a CBD pain-relieving cream available under Ireland Men One, a men’s lifestyle brand focused on millennials.

The cannabis industry is already seeing huge growth, creating jobs and wealth. With legal reform in the United States and the momentum provided by e-commerce, this growth appears set to continue for a long time to come.

For more information on SinglePoint, visit SinglePoint, Inc. (OTCQB: SING)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – US Federal Government Sends Out Advert for Cannabis Cultivators

The Federal Business Opportunities website recently featured an advert of great interest to the cannabis industry. In that advert, the federal government was inviting entities to submit their capability statements if they felt they could grow or supply different quantities of marijuana strains or products.

The advert stipulates that any firms interested in the opportunity should have the capacity to store at least 5000 kilos of marijuana.

This advert is good news to the cannabis industry because for long, it has been difficult to get hold of cannabis for research purposes. This is because the only federally-licensed producer, Mississippi University, could not meet the quantity and quality requirements of the marijuana needed for clinical trials and other research purposes. The sole cultivator was licensed in 1968 and that is how the situation remained for all these decades.

The advert also explains that any prospective cultivator should have the ability to grow or procure cannabis having different concentrations of CBD and THC from reputable foreign sources.

It will also be mandatory for the selected suppliers to manufacture standardized cannabis cigarettes.

Needless to say, the advert also asked interested companies to apply only if they have the capacity to ship cannabis securely to scientists in different locations around the country. FDA quality requirements will be adhered to for any manufacturing or storage facility used by the producers.

You should remember that this announcement comes a few months after University College San Diego got permission to import marijuana capsules from Canada since those needed products couldn’t be obtained within U.S. borders. The cannabis was to be used for clinical trials aimed at finding a treatment for childhood autism.

The invitation sent out by the federal government will therefore open the way for large cannabis industry players to take part in making it possible for scientific research on cannabis to be conducted in the US.

This business opportunity advert comes at a time when the news of the resignation of Jeff Sessions as Attorney General is still fresh in the cannabis industry and around the country. Could his presence in office have delayed the making of such decisions since he was so opposed to any form of cannabis legalization?

Industry players like Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: 03X4) and SinglePoint, Inc. (OTCQB: SING) can only hope that the companies which will be selected at the end of the screening process will deliver cannabis whose quality is high enough for research purposes unlike what has been previously available from federal sources.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com